Statin-Associated Polymyalgia Rheumatica. An Analysis Using WHO Global Individual Case Safety Database: A Case/Non-Case Approach

Hilda J. I. de Jong; Siti R. F. Saldi; Olaf H. Klungel; Rob J. Vandebriel; Patrick C. Souverein; Ronald H. B. Meyboom; J. L. M. (Anneke) Passier; Henk van Loveren; Jan Willem Cohen Tervaert

doi:10.1371/journal.pone.0041289

Loading metrics

Open Access

Peer-reviewed

Research Article

Statin-Associated Polymyalgia Rheumatica. An Analysis Using WHO Global Individual Case Safety Database: A Case/Non-Case Approach

Hilda J. I. de Jong,

Affiliations Laboratory for Health Protection Research, National Institute for Public Health and the Environment, Bilthoven, Netherlands, Department of Toxicogenomics, Maastricht University Medical Centre, Maastricht, Netherlands, Division of Pharmacoepidemiology and Clinical Pharmacology, Department of Pharmaceutical Sciences, Faculty of Sciences, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, Netherlands
⨯
Siti R. F. Saldi,

Affiliation Division of Pharmacoepidemiology and Clinical Pharmacology, Department of Pharmaceutical Sciences, Faculty of Sciences, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, Netherlands
⨯
Olaf H. Klungel,

Affiliation Division of Pharmacoepidemiology and Clinical Pharmacology, Department of Pharmaceutical Sciences, Faculty of Sciences, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, Netherlands
⨯
Rob J. Vandebriel,

Affiliation Laboratory for Health Protection Research, National Institute for Public Health and the Environment, Bilthoven, Netherlands
⨯
Patrick C. Souverein,

Affiliation Division of Pharmacoepidemiology and Clinical Pharmacology, Department of Pharmaceutical Sciences, Faculty of Sciences, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, Netherlands
⨯
Ronald H. B. Meyboom,

Affiliations Division of Pharmacoepidemiology and Clinical Pharmacology, Department of Pharmaceutical Sciences, Faculty of Sciences, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, Netherlands, Uppsala Monitoring Centre, World Health Organisation Collaborating Centre for International Drug Monitoring, Uppsala, Sweden
⨯
J. L. M. (Anneke) Passier,

Affiliation Netherlands Pharmacovigilance Centre Lareb, ’s-Hertogenbosch, Netherlands
⨯
Henk van Loveren,

Affiliations Laboratory for Health Protection Research, National Institute for Public Health and the Environment, Bilthoven, Netherlands, Department of Toxicogenomics, Maastricht University Medical Centre, Maastricht, Netherlands
⨯
Jan Willem Cohen Tervaert

* E-mail: jw.cohentervaert@maastrichtuniversity.nl

Affiliation Division of Clinical and Experimental Immunology, Department of Internal Medicine, Maastricht University Medical Centre, Maastricht, Netherlands
⨯

Statin-Associated Polymyalgia Rheumatica. An Analysis Using WHO Global Individual Case Safety Database: A Case/Non-Case Approach

Hilda J. I. de Jong,
Siti R. F. Saldi,
Olaf H. Klungel,
Rob J. Vandebriel,
Patrick C. Souverein,
Ronald H. B. Meyboom,
J. L. M. (Anneke) Passier,
Henk van Loveren,
Jan Willem Cohen Tervaert

Published: July 23, 2012
https://doi.org/10.1371/journal.pone.0041289

Reader Comments (0)

Post a new comment on this article

Subject Areas
?

For more information about PLOS Subject Areas, click here.
We want your feedback. Do these Subject Areas make sense for this article? Click the target next to the incorrect Subject Area and let us know. Thanks for your help!

Statins
Is the Subject Area "Statins" applicable to this article?

Thanks for your feedback.
Adverse reactions
Is the Subject Area "Adverse reactions" applicable to this article?

Thanks for your feedback.
NSAIDs
Is the Subject Area "NSAIDs" applicable to this article?

Thanks for your feedback.
Physicians
Is the Subject Area "Physicians" applicable to this article?

Thanks for your feedback.
Polymyalgia rheumatica
Is the Subject Area "Polymyalgia rheumatica" applicable to this article?

Thanks for your feedback.
Antihypertensive drugs
Is the Subject Area "Antihypertensive drugs" applicable to this article?

Thanks for your feedback.
Adverse events
Is the Subject Area "Adverse events" applicable to this article?

Thanks for your feedback.
Drug safety
Is the Subject Area "Drug safety" applicable to this article?

Thanks for your feedback.